Skip to main content

Published locations for Unresectable mCRC: Final survival outcomes with first-line trifluridine/tipiracil plus bevacizumab in TASCO1

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Unresectable mCRC: Final survival outcomes with first-line trifluridine/tipiracil plus bevacizumab in TASCO1

User login

  • Reset your password
  • /content/unresectable-mcrc-final-survival-outcomes-first-line-trifluridine/tipiracil-plus-bevacizumab
  • /hematology-oncology/article/255012/gastrointestinal-cancer/unresectable-mcrc-final-survival-outcomes